EFFECT OF SELECTED POLYMERS ON DISSOLUTION AND STABILIZATION OF AMORPHOUS FORM OF MELOXICAM
Objective: Meloxicam is classified as class II corresponding to its high permeability and low solubility (12Î¼g/ml). This study aims to compare the effect of selected polymers on stabilization of amorphous form, and dissolution of meloxicam by preparation of different solid dispersions using selected polymers (chitosan oligomers, polyvinylpyrrolidone K30, and polyethylene glycols).
Methods: These solid dispersions were prepared using two different methods; solvent evaporation method for the two molecular weights chitosan carriers (16 and 11KDa) and polyvinylpyrrolidone-K30 and melting method for the two different molecular weights polyethylene glycol (4000 and 6000). The physicochemical properties of solid dispersions were analyzed using differential scanning calorimetry, Fourier transform infra-red analysis, Powder X-ray diffraction, and scanning electron microscopy. Selected dispersions were then compared to two selected marketed drugs (MobicÂ® and MovenÂ®).
Results: Best dissolution rates were obtained for both polyvinylpyrrolidone-K30 and polyethylene glycol 6000, followed by chitosan 16 kDa, chitosan 11 kDa, and polyethylene glycol 4000. Increasing polymeric ratio increased dissolution rate except for chitosan. Precipitation of the drug as amorphous form occurred in chitosan and polyvinylpyrrolidone-K30 dispersions, while no change in crystallinity obtained for polyethylene glycol dispersions. Failure of polyvinylpyrrolidone-K30 in the maintenance of stability during storage time was observed while re-crystallization occurred in chitosan-based dispersions, which ends with preferences to polyethylene glycol dispersions. After comparing the release of selected dispersions with the two selected polymers; all dispersions got a higher release than that of the two marketed drugs release.
Conclusion: The dissolution profile of meloxicam has been increased successfully in a reproducible manner.
2. Kulkarni U, Patil B, Hariprasanna RC, Borgaonkar P, Hogade M, Rabbani G. Formulation and development of fast dissolving meloxicam tablets by solid dispersion technique: for the effective treatment of dental pain. Int J Curr Pharm Res 2010;2:82-5.
3. Ghareeb M, Abdulrasool A, Hussein A, Noordin M. Kneading technique for preparation of binary solid dispersion of meloxicam with poloxamer 188. AAPS PharmSciTech 2009;10:1206-16.
4. Samprasit W, Akkaramongkolporn P, Ngawhirunpat T, Rojanarata T, Opanasopit P. Meloxicam taste-masked oral disintegrating tablet with dissolution enhanced by ion exchange resins and cyclodextrin. AAPS PharmSciTech 2013;14:1118-26.
5. Hu L, Gu D, Hu Q, Shi Y, Gao N. Investigation of solid dispersion of atorvastatin calcium in polyethylene glycol 6000 and polyvinylpyrrolidone. Tropical J Pharm Res 2014;13:835.
6. Ohara T, Kitamura S, Kitagawa T, Terada K. Dissolution mechanism of poorly water-soluble drug from extended release solid dispersion system with ethylcellulose and hydroxypropylmethylcellulose. Int J Pharm 2005;302:95-102.
7. More S, Sontakke S. Solubility enhancement of gliclazide by solid dispersion method. Asian J Pharm Clin Res 2013;6 Suppl 5:91-8.
8. Kurmi R, Mishra D, Jain D. Solid dispersion: a novel means of solubility enhancement. J Crit Rev 2016;3:1-8.
9. Mendhe A, Kharwade R, Mahajan U. Dissolution enhancement of poorly water-soluble drug by cyclodextrinsinclusion complexation. Int J Appl Pharm 2016;8:60-5.
10. Rinaudo M. Chitin and chitosan: properties and applications. Prog Polym Sci 2006;31:603-32.
11. Zhang X, Sun N, Wu B, Lu Y, Guan T, Wu W. Physical characterization of lansoprazole/PVP solid dispersion prepared by fluid-bed coating technique. Powder Technol 2008;182:480-5.
12. Biswal S, Sahoo J, Murthy P, Giradkar R, Avari J. Enhancement of dissolution rate of gliclazide using solid dispersions. With polyethylene glycol 6000. AAPS PharmSciTech 2008;9:563-70.
13. Obaidat R, Al-Jbour N, Al-Souâ€™d K, Sweidan K, Al-Remawi M, Badwan A. Some physico-chemical properties of low molecular weight chitosans and their relationship to conformation in aqueous solution. J Solution Chem 2010;39:575-88.
14. Induri M, Mantripragada B, Yejella R, Kunda P, Nannapaneni P, Boddu R. Dissolution studies and quantification of meloxicam in tablet dosage form by spectrophotometry. Pak J Pharm Sci 2012;25:283-7.
15. Obaidat R, Tashtoush B, Awad A, Al Bustami R. Using supercritical fluid technology (SFT) in preparation of tacrolimus solid dispersions. AAPS PharmSciTech 2017;18:481-93.
16. Oliveira E, Azevedo R, Bonfilio R, Oliveira D, Ribeiro G, AraÃºjo M. Dissolution test optimization for meloxicam in the tablet pharmaceutical form. Brazilian J Pharm Sci 2009;45:68-73.
17. Obaidat R, Tashtoush B, Bayan M, Al Bustami R, Alnaief M. Drying using supercritical fluid technology as a potential method for preparation of chitosan aerogel microparticles. AAPS PharmSciTech 2015;16:1235-44.
18. Costa P, Lobo J. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001;13:123-33.
19. Sinha P, Jeswani R, Topagi K, Damale M. A validated RP-HPLC method for determination of meloxicam in the presence of its impurities. Int J PharmTech Res 2009;1:1051-60.
20. Gonza Lez-RodrÄ± Guez M, Holgado M, Mah, Sa Nchez-Lafuente C, Rabasco A, Fini A. Alginate/Chitosan particulate systems for sodium diclofenac release. Int J Pharm 2002;232:225-34.
21. El-Badry M, Fathy M. Enhancement of the dissolution and permeation rates of meloxicam by formation of its freeze-dried solid dispersions in polyvinylpyrrolidone K-30. Drug Dev Ind Pharm 2006;32:141-5.
22. Saleem M, Bala S. Formulation and evaluation of meloxicam solid dispersion incorporated topical gels. Int J Pharma Bio Sci 2010;1:1-9.
23. Ujang Z, Diah M, Abdul Rashid A, Halim A. The development, characterization and application of water soluble chitosan. Biotechnol Polymers 2011;6:110-27.
24. Frizon F, Eloy J, Donaduzzi C, Mitsui M, Marchetti J. Dissolution rate enhancement of loratadine in polyvinylpyrrolidone K-30 solid dispersions by solvent methods. Powder Technol 2013;235:532-9.
25. Ko J, Park H, Hwang S, Park J, Lee J. Preparation and characterization of chitosan microparticles intended for controlled drug delivery. Int J Pharm 2002;249:165.
26. Paradkar A, Ambike A, Jadhav B, Mahadik K. Characterization of curcuminâ€“PVP solid dispersion obtained by spray drying. Int J Pharm 2004;271:1-2.
27. Fini A, Cavallari C, Ospitali F. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles. Eur J Pharm Biopharm 2008;70:409-20.
28. Abdelrazek E, Ragab H, Abdelaziz M. Physical characterization of poly (Vinyl Pyrrolidone) and gelatin blend films doped with magnesium chloride. Plastic Polymer Technol (PAPT) 2013;2:1-8.
29. Bolourchiana N, Mahboobian M, Dadashzadeh S. The effect of PEG molecular weights on dissolution behavior of simvastatin in solid dispersions. Iranian J Pharm Res 2013;12:12-20.
30. Guleria R, Kaith N, Singh R. PEG based SDs of gliclazide: a comparative study. Int J Pharm Pharm Sci 2012;4:507-11.
31. Shashikant D, Barhate GAS, Ankit S Sharma, Prashant DN. Formulation of fast dissolving tablets of Meloxicam. J Pharm Res 2009;2:646-50.
32. Mura P, Zerrouk N, Mennini N, Maestrelli F, Chemtob C. Development and characterization of naproxenâ€“chitosan solid systems with improved drug dissolution properties. Eur J Pharm Sci 2003;19:67-75.
33. Gong K, Darr J, Rehman I. Supercritical fluid assisted impregnation of indomethacin into chitosan thermosets forcontrolled release applications. Int J Pharm 2006;315:93-8.
34. Gurusamy S, Kumar V, Mishra D. Preparation, characterization and in vitro dissolution studies of solid dispersion of meloxicam with PEG 6000. Yakugaku Zasshi 2006;126:657-64.
35. Pathak D, Dahiya S, Pathak K. Solid dispersion of meloxicam: factorially designed dosage form for geriatric population. Acta Pharm 2008;58:99-110.
36. Gurusamy S, Kumar V, Mishra D. Preparation and evaluation of solid dispersion of meloxicam with skimmed milk. Yakugaku Zasshi 2006;126:93-7.
37. Shiraishi S, Arahira M, Imai T, Otagiri M. Enhancement of dissolution rates of several drugs by low-molecular chitosan and alginate. Chem Pharm Bull 1990;38:185-7.
38. Bansal V, Kumar P, Sharma N, Pal O, Malviya R. Applications of chitosan and chitosan derivatives in drug delivery. Adv Biol Res (Rennes) 2011;5:28-37.
39. Craig D. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm 2002;231:131-44.
40. Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2002;50:47-60.
41. Jameela S, Kumary T, Lal A, Jayakrishnan A. Progesterone-loaded chitosan microspheres: a long acting biodegradable controlled delivery system. J Controlled Release 1998;52:17-24.
42. Ahuja N, Katare O, Singh B. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers. Eur J Pharm Biopharm 2007;65:26-3.
43. Caron V, Hu Y, Tajber L, Erxleben A, Corrigan O, Mcardle P, et al. Amorphous solid dispersions of sulfonamide/SoluplusÂ® and sulfonamide/PVP prepared by ball milling. AAPS PharmSciTech 2013;14:464-74.